European Biotechnology Winter 2026
Preview
© www.istockphoto.com/vchal
Gene editing
Winter 2026
SPECIAL
Publication date: 26 November, 2026
Gene editing From genetic correction to clinical impact Gene editing is creating new opportunities to treat disease by making precise changes to DNA. From CRISPR-Cas systems to base and prime editing, the field brings together advances in molecular engineering, delivery technologies and cell therapy. Turning these tools into treatments requires solutions to complex challenges: reaching the right tissues, minimizing unintended edits, achieving durable effects and developing scalable manufacturing processes. In its Winter 2026 issue, European Biotechnology will spotlight the companies, technologies and partnerships shaping Europe’s gene editing sector, from emerging platforms and therapeutic applications to the expertise needed to bring them into clinical development.
Present your expertise Drug developers, delivery specialists, technology providers, CDMOs, CROs, equipment suppliers and analytical service providers will have the opportunity to present their latest products, processes and innovations in this special feature. European Biotechnology Magazine reaches decision-makers throughout the European life sciences sector and, through our official partner SLAS, in the USA. Showcase your expertise to potential customers and partners working across gene editing research, development, manufacturing and clinical delivery.
Examples of topics CRISPR-Cas systems, base editing, prime editing, gene insertion, in vivo and ex vivo editing, gene-edited cell therapies, rare genetic diseases, hematology, oncology, liver and muscle targeting, viral and nonviral delivery, lipid nanoparticles, guide RNA design, nuclease engineering, off-target analysis, genomic integrity, functional screening, process development, GMP manufacturing, potency assays, clinical trial design, long-term follow-up, regulatory strategy and intellectual property.
Editorial Deadline 12-11-2026
Booking Deadline 12-11-2026
Publication Date 26-11-2026
Editorial contact:: Joachim Eeckhout Tel.: +49-30-264921-29 joachim.eeckhout@knowb.io
Marketing contact: Oliver Schnell Tel.: +49-30-264921-45 oliver.schnell@knowb.io
Marketing contact: Andreas Macht Tel.: +49-30-264921-54 andreas.macht@knowb.io
Knowbio GmbH I Lessingstr. 12 I 16552 Mühlenbecker Land I www.knowb.io